Indiana Biosciences Research Institute
FormationMay 1, 2013 (2013-05-01)
TypeResearch Institute
HeadquartersIndianapolis, Indiana, U.S.
Region served
Indiana
Staff
100
Websitehttp://indianabiosciences.org

The Indiana Biosciences Research Institute (IBRI) is an American nonprofit translational research organization headquartered in Indianapolis, Indiana, United States[1] within the 16 Tech Innovation District.[2] The IBRI is the nation's first industry-led collaborative life sciences research institute.[3] Its primary focus is on better understanding the pathogenesis of type 1 and type 2 diabetes to translate this knowledge into novel therapies,[4] while also expanding into other metabolic diseases that share common systems and pathways.[5]

History

In 2012, pharmaceutical executive John C. Lechleiter from Eli Lilly & Company initially proposed the IBRI.[6][7] In 2013, Indiana governor Mike Pence announced the formation of the IBRI.[8] Pence later worked with life sciences leaders to secure $25 million in startup funds from the state.[9]

In 2015, the IBRI hired David Broecker as CEO.[10] In late 2015, the Indianapolis City-County Council approved $75 million to build a technology park called 16 Tech.[11] In 2016, the IBRI hired Rainer Fischer as Chief Scientific Officer.[12][13] In 2017, Governor Eric Holcomb reaffirmed the commitment made by his predecessor Mike Pence.[14][15][16]

Leadership

Appointees to the IBRI’s Board of Directors include:

References

  1. ↑ Rudavsky, Shari (February 24, 2016). "New biosciences institute gets $100M". Indianapolis Star. Retrieved June 22, 2017.
  2. ↑ Orr, Susan (March 16, 2022). "16 Tech Promotes Emily Krueger to Chief Executive". Indianapolis Business Journal. Retrieved August 15, 2022.
  3. ↑ "Bioscience Research Institute Creates a 'Petri Dish' for Innovation". Crain Communications. June 30, 2016. Retrieved June 22, 2017.
  4. ↑ "IBRI Welcomes New Leader". Inside INdiana Business. Retrieved 2022-08-16.
  5. ↑ "How We Study Alzheimer's and Potential Treatments". Indiana University Precision Health Initiative, Healthcare Triage. Retrieved 2022-08-16.
  6. ↑ Lechleiter, John (March 31, 2015). "From hunting to farming, medicines development takes a big leap forward". Forbes. Retrieved June 22, 2017.
  7. ↑ Pogorelc, Deanna (May 30, 2013). "Eli Lilly, Roche, device makers collaborate on new public-private research institute in Indiana". MedCity News. Retrieved June 22, 2017.
  8. ↑ Pence, Mike (May 30, 2013). "Governor Pence Announces Indiana Biosciences Research Institute". YouTube. Retrieved June 22, 2017.
  9. ↑ Nather, David (July 16, 2016). "With Pence pick, Trump just made women's health a top-tier election issue". PBS. Retrieved June 22, 2017.
  10. ↑ Swiatek, Jeff (May 19, 2015). "New CEO of bioscience institute looks to hire researchers, raise millions". Indianapolis Star. Retrieved June 22, 2017.
  11. ↑ Eason, Brian (November 9, 2015). "City-County Council OKs $75M for Indianapolis tech park". USA Today. Retrieved June 22, 2017.
  12. ↑ Ober, Andy (October 4, 2016). "IBRI hires European bioscience giant". Inside INdiana Business. Retrieved June 22, 2017.
  13. ↑ Russell, John (April 1, 2017). "FOCUS: Biosciences institute's chief scientific officer aims to foster commercialization". Indianapolis Business Journal. Retrieved June 22, 2017.
  14. ↑ Redman, Mary-Rachel (January 16, 2017). "Roche CEO: IBRI Will Succeed Where Others Have Failed". Inside INdiana Business. Retrieved June 22, 2017.
  15. ↑ Lange, Kaitlin (April 21, 2017). "How Gov. Holcomb's priorities fared in the state budget". Indianapolis Star. Retrieved June 22, 2017.
  16. ↑ Heinz, Katie (January 5, 2017). "Governor-elect Eric Holcomb unveils 2017 legislative agenda". WRTV. Retrieved June 22, 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.